Clinical features and outcomes of interstitial lung disease in anti-Jo-1 positive antisynthetase syndrome

Interstitial lung disease (ILD) is a common extra-muscular manifestation of antisynthetase (AS) syndrome. ILD prevalence is higher with anti-Jo-1 antibody positivity. Data on long-term outcomes in these patients are lacking.

Source: Respiratory Medicine CME - July 14, 2016 Category: Respiratory Medicine Authors: Ana C. Zamora, Sumedh S. Hoskote, Beatriz Abascal-Bolado, Darin White, Christian W. Cox, Jay H. Ryu, Teng Moua Tags: Clinical Trial Paper Source Type: research